Navigation Links
Vista Partners Initiates Coverage on Helix BioPharma Corporation; Target Price $6.20
Date:5/10/2011

SAN FRANCISCO, May 10, 2011 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on Helix BioPharma Corporation (AMEX: HBP, TSX: HBP) ("the Company") with a twelve month target price of $6.20. Ross Silver, Principal Analyst at Vista Partners stated, "The Company is developing products for the treatment and prevention of cancer. The first and most advanced, Interferon alpha-2b, is a potent immuno-modulatory drug compound that has been formulated as a topical cream ("TIFNα2b") using Helix's unique, patented Biphasix™ platform technology which is intended to resolve low-grade cervical intraepithelial neoplasia grade 1 or 2 ("CIN 1 or 2") lesions. We believe TIFNα2b, if approved, could have revenues in excess of $500M globally, given the fact that the prospective market size is considerable, with approximately 1.3 million new cases of low-grade cervical lesions diagnosed annually each year in the U.S. alone today for which there are no approved pharmaceutical therapies." Mr. Silver concludes, "The Company's L-DOS47 is the first targeted therapeutic immunoconjugate under development based upon Helix's DOS47 technology. Helix's L-DOS47 is a new drug in development that is intended to offer an innovative approach to the first-line treatment of inoperable, locally advanced, recurrent or metastatic non-small cell lung cancer ("NSCLC")."

To download a FREE copy of the Helix BioPharma Corporation research report, please visit http://www.vistapglobal.com and click the "download research" icon to gain access to the report.

About Vista Partners:

Vista Partners LLC was founded in 2005 and has offices in California and one in Oregon. Vista Partners LLC is a Registered Investment Advisor in the States of California and Oregon. The firm's p
'/>"/>

SOURCE Vista Partners
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
3. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
4. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
5. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
6. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
7. NeoVista, Inc. Presents New Data on Its Novel Wet AMD Therapy at AAO
8. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
9. NeoVista Presents One Year Data on Novel Wet AMD Therapy at Macula Society
10. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
11. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015  Obsidian HDS, the developer of PharmaShine ... for the management of data on pharmaceutical and device ... now includes the 2014 Open Payments General and Research ... June 30. The data disclosed on Open Payments for ... and providers totaling $6.49 billion and is the largest ...
(Date:7/2/2015)... HILL, N.C. , July 2, 2015 /PRNewswire/ ... own employees to capture critical product and market ... are many benefits to employee-based studies, it is ... leverage their own internal employees to capture critical ... study by benchmarking firm, Best Practices, LLC, most ...
(Date:7/2/2015)... Fla. , July 2, 2015  Fort ... is pleased to announce that its Consumer Group ... Beverages") to Kerry Group plc (ISE: KRZ) ("Kerry"), ... taste and nutrition systems, as well as functional ... and pharmaceutical markets. Farlie Turner served as the ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is ... dresses similar to those of celebrities will have the opportunity to get 10% discount ... This ensures that people do not have to use coupon codes or remember redemption ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on obesity ... society right now," Becic said. "We must understand the magnitude of this discovery. For ...
(Date:7/2/2015)... ... ... swing, Americans are flocking to Canada’s many lakes to reel in their fair share of ... it’s easy to understand why. From the Pacific Northwest Coast of British Columbia to the ... huge industry, and Americans make up the vast majority of anglers from outside of Canada. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready to hit ... SOCKS. Since the socks were first introduced, they have rapidly been gaining attention ... inspired four new, fun shades including: blue, lime, pink and red. , ...
(Date:7/2/2015)... CA (PRWEB) , ... July 02, 2015 , ... ActiveBunch.com ... a passion for social fitness. Built to function as a lifestyle community, Active Bunch ... them the opportunity to network, meet, and participate in discussions or group events. ...
Breaking Medicine News(10 mins):Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2
... High antiretroviral therapy adherence, which has been shown to ... survival, is now associated with lower health care costs, ... of Public Health. Researchers examined the effect of antiretroviral ... that antiretroviral therapy improves health outcomes for people infected ...
... Hopkins University determined that immune responses to the tetanus ... methotrexate (MTX) was compared with MTX alone in patients ... vaccination (Pneumovax pneumonia vaccine), however, were reduced in RA ... are published in the January 2010 issue of ...
... recent evaluation by the Centre for Addiction and Mental Health ... be effective in changing drinking behaviours and offers a significant ... its kind, the study published in Addiction found ... reduced their alcohol consumption by 30% - or six to ...
... in prostate cancer patients receiving external beam radiation therapy ... but then stabilizes and does not continuously decline as ... January 1 issue of the International Journal of ... Society for Radiation Oncology (ASTRO). Prostate cancer is ...
... a multi-bed hospital room dramatically increases the risk of acquiring ... A new study led by infectious diseases expert Dr. Dick ... C. difficile ( Clostridium difficile ) rises with ... in a two, three or four-bedded room, each time you ...
... EDITOR,S PICK: Depleting breast cancerinitiating cells by targeting the ... many types of cancer, including breast cancer, are initiated ... the tumor known as cancer stem cells. These cells ... and recurrence after treatment, meaning that many researchers are ...
Cached Medicine News:Health News:High antiretroviral therapy adherence associated with lower health care costs 2Health News:Immune responses to tetanus vaccine unchanged for RA patients on rituximab 2Health News:Technology new gateway into treatment for problem alcohol users: Study 2Health News:Sexual function does not continuously decline after radiation therapy treatments for prostate cancer 2Health News:Sharing a hospital room increases risk of 'super bugs' 2Health News:JCI online early table of contents: January 4, 2009 2Health News:JCI online early table of contents: January 4, 2009 3Health News:JCI online early table of contents: January 4, 2009 4
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
... PulseOx 5500TM is the worlds first ... saturation and heart rate to use ... 5500TM uses SPO Medicals patented technology ... is more usable for many patients ...
All-in-One Fingertip Oximeter...
The reliable and easy-to-use 3900/P pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
Medicine Products: